https://www.selleckchem.com/pr....oducts/bgj398-nvp-bg
However, the prophylactic and treatment dose groups were not significantly different. The hierarchy for efficacy in reducing short-term mortality was treatment dose (P score 92.4) prophylactic dose (57.6) no treatment (0.. In patients with severe COVID-19, due to the absence of trials with the no-treatment group, NMA could not be conducted. However, pairwise comparison did not show a significant difference between the prophylactic and treatment dose groups. Treatment and prophylactic doses of anticoagulants showed
Like
Comment
Share
